Home/Pipeline/Oncology Platform Discovery

Oncology Platform Discovery

Pancreatic Cancer / Solid Tumors

Pre-clinicalActive

Key Facts

Indication

Pancreatic Cancer / Solid Tumors

Phase

Pre-clinical

Status

Active

Company

Renovaro BioSciences

About Renovaro BioSciences

Renovaro BioSciences, founded in 2013 and based in Los Angeles, is developing an AI-driven biology platform under the Lunai Bioworks banner to transform drug discovery. The company integrates genomic, proteomic, and phenotypic data with high-throughput in vivo modeling to uncover disease mechanisms and therapeutic candidates with higher precision. It is advancing internal programs in oncology and neurology while also pursuing strategic partnerships with pharmaceutical companies. Renovaro is a public company, positioning itself at the intersection of AI and biologics to address complex diseases.

View full company profile

Therapeutic Areas

Oncology Neurology Biosecurity

Other Pancreatic Cancer / Solid Tumors Drugs

Drug	Company	Phase	Status
CART-ANT308	Cambium Oncology	Pre-clinical	Active
SereneRF for Soft Tissue Tumors	Thermedical	Early Clinical	Active